Alternating Consumption of β-glucan and Quercetin Reduces Mortality in Mice with Colorectal Cancer
Overview
Authors
Affiliations
The current dietary recommendations for disease prevention and management are scarce and are not well supported. Beta-glucan or quercetin in a diet can alleviate colorectal cancer (CRC) by regulating the gut microbiota and related genes, but the effects of alternating their consumption for routine ingestion during CRC occurrence remain unknown. This study investigated the effects of alternating the consumption of β-glucan and quercetin for routine ingestion on CRC development in mice. The mortality rate, colonic length, inflammatory cytokines, gut microbiota, and colonic epithelial gene expression in healthy and CRC mice that consumed normal and alternate diets were compared and studied. The results showed that alternating the consumption of β-glucan and quercetin (alternating among a β-glucan diet, a normal diet and a normal diet that was supplemented with quercetin) alleviated colon damage and reduced the mortality rate in CRC mice, with a reduction in mortality of 12.5%. Alternating the consumption of β-glucan and quercetin significantly decreased the TNF-α level, increased the relative abundance of and downregulated three genes ( and ) that are associated with inflammation and cancer. Alternating the consumption of some bioactive compounds, such as β-glucan and quercetin, in food can contribute to human health. This experiment provided some experimental evidence for the dietary recommendations for disease prevention and management.
Linking dietary fiber to human malady through cumulative profiling of microbiota disturbance.
Zhang X, Liu H, Li Y, Wen Y, Xu T, Chen C Imeta. 2025; 4(1):e70004.
PMID: 40027480 PMC: 11865338. DOI: 10.1002/imt2.70004.
From nature to clinic: Quercetin's role in breast cancer immunomodulation.
Fang L, Gao D, Wang T, Zhao H, Zhang Y, Wang S Front Immunol. 2024; 15:1483459.
PMID: 39712006 PMC: 11659267. DOI: 10.3389/fimmu.2024.1483459.
Yoyo Dieting, Post-Obesity Weight Loss, and Their Relationship with Gut Health.
Phuong-Nguyen K, McGee S, Aston-Mourney K, Mcneill B, Mahmood M, Rivera L Nutrients. 2024; 16(18).
PMID: 39339770 PMC: 11435324. DOI: 10.3390/nu16183170.
β-glucan: a potent adjuvant in immunotherapy for digestive tract tumors.
Wang M, Pan J, Xiang W, You Z, Zhang Y, Wang J Front Immunol. 2024; 15:1424261.
PMID: 39100668 PMC: 11294916. DOI: 10.3389/fimmu.2024.1424261.
glucans: a potential source for maintaining gut microbiota and the immune system.
Singh R, Bhardwaj A Front Nutr. 2023; 10:1143682.
PMID: 37215217 PMC: 10198134. DOI: 10.3389/fnut.2023.1143682.